Q14247 (SRC8_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 136.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Src substrate cortactin Alternative name(s): Amplaxin Oncogene EMS1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 550 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Contributes to the organization of the actin cytoskeleton and cell structure. In complex with ABL1 and MYLK regulates cortical actin-based cytoskeletal rearrangement critical to sphingosine 1-phosphate (S1P)-mediated endothelial cell (EC) barrier enhancement. Plays a role in the regulation of cell migration. Plays a role in the invasiveness of cancer cells, and the formation of metastases. Ref.26 Ref.29 |
| Subunit structure | Interacts with SHANK2 and SHANK3 (via its SH3 domain). Also interacts with FGD1. Identified in a complex containing FGFR4, NCAM1, CDH2, PLCG1, FRS2, SRC, SHC1, GAP43 and CTTN. Interacts with ABL2 By similarity. Interacts with PLXDC2 and SRCIN1. Interacts with SAMSN1 (via SH3 domain). Interacts (via SH3 domain) with ASAP1 (via Pro-rich region). Interacts with DNM2 and FER. Forms a complex made of ABL1 and MYLK. Interacts with CTTNBP2NL; this interaction may target CTTN to stress fibers. Interacts with CTTNBP2; this interaction may target CTTN at the cell cortex or dendritic spines. Ref.7 Ref.8 Ref.10 Ref.20 Ref.23 Ref.26 Ref.29 |
| Subcellular location | Cytoplasm › cytoskeleton. Cell projection › lamellipodium. Cell projection › ruffle. Cell projection › dendrite By similarity. Cell projection › dendritic spine By similarity. Note: Associated with membrane ruffles and lamellipodia. In the presence of CTTNBP2NL, colocalizes with stress fibers By similarity. In the presence of CTTNBP2, localizes at the cell cortex By similarity. In response to neuronal activation by glutamate, redistributes from dendritic spines to the dendritic shaft By similarity. Ref.2 Ref.7 Ref.26 Ref.29 |
| Domain | The SH3 motif may mediate binding to the cytoskeleton. |
| Post-translational modification | Phosphorylated by PKN2 at both serine and threonine residues in a GTP-bound Rac1-dependent manner in hyaluronan-induced astrocytes and hence down-regulated CTTN ability to associates with filamentous actin By similarity. Phosphorylated by FER. Tyrosine phosphorylation in transformed cells may contribute to cellular growth regulation and transformation. Phosphorylated in response to FGR activation. Phosphorylation by SRC promotes MYLK binding. Ref.7 Ref.8 Ref.11 |
| Sequence similarities | Contains 7 cortactin repeats. Contains 1 SH3 domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell projection Cytoplasm Cytoskeleton |
| Coding sequence diversity | Alternative splicing |
| Domain | Repeat SH3 domain |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | cell cortex Inferred from sequence or structural similarity. Source: UniProtKB cytoskeletonTraceable author statement PubMed 9054437. Source: ProtInc lamellipodiumInferred from sequence or structural similarity. Source: UniProtKB ruffleInferred from sequence or structural similarity. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| Srcin1 | Q9QWI6-2 | 2 | EBI-351886,EBI-775607 | From a different organism. |
| WAS | P42768 | 3 | EBI-351886,EBI-346375 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q14247-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q14247-2) The sequence of this isoform differs from the canonical sequence as follows: 264-300: Missing. 538-550: YGLFPANYVELRQ → FRELAFSCVR...CLGTWVPECP | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q14247-3) The sequence of this isoform differs from the canonical sequence as follows: 264-300: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||
Molecule processing | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 550 | 550 | Src substrate cortactin | PRO_0000072189 | |||||||||||||||||
Regions | |||||||||||||||||||||
| Repeat | 80 – 116 | 37 | Cortactin 1 | ||||||||||||||||||
| Repeat | 117 – 153 | 37 | Cortactin 2 | ||||||||||||||||||
| Repeat | 154 – 190 | 37 | Cortactin 3 | ||||||||||||||||||
| Repeat | 191 – 227 | 37 | Cortactin 4 | ||||||||||||||||||
| Repeat | 228 – 264 | 37 | Cortactin 5 | ||||||||||||||||||
| Repeat | 265 – 301 | 37 | Cortactin 6 | ||||||||||||||||||
| Repeat | 302 – 324 | 23 | Cortactin 7; truncated | ||||||||||||||||||
| Domain | 492 – 550 | 59 | SH3 | ||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||
| Modified residue | 87 | 1 | N6-acetyllysine Ref.22 | ||||||||||||||||||
| Modified residue | 198 | 1 | N6-acetyllysine Ref.22 | ||||||||||||||||||
| Modified residue | 235 | 1 | N6-acetyllysine Ref.22 | ||||||||||||||||||
| Modified residue | 272 | 1 | N6-acetyllysine Ref.22 | ||||||||||||||||||
| Modified residue | 304 | 1 | N6-acetyllysine Ref.22 | ||||||||||||||||||
| Modified residue | 309 | 1 | N6-acetyllysine Ref.22 | ||||||||||||||||||
| Modified residue | 399 | 1 | Phosphothreonine Ref.24 | ||||||||||||||||||
| Modified residue | 401 | 1 | Phosphothreonine Ref.24 | ||||||||||||||||||
| Modified residue | 405 | 1 | Phosphoserine Ref.9 Ref.13 Ref.14 Ref.16 Ref.17 Ref.19 Ref.21 Ref.24 | ||||||||||||||||||
| Modified residue | 411 | 1 | Phosphothreonine Ref.19 | ||||||||||||||||||
| Modified residue | 417 | 1 | Phosphoserine Ref.19 | ||||||||||||||||||
| Modified residue | 418 | 1 | Phosphoserine Ref.14 Ref.19 Ref.21 Ref.24 Ref.27 | ||||||||||||||||||
| Modified residue | 421 | 1 | Phosphotyrosine; by SRC Ref.17 Ref.21 | ||||||||||||||||||
| Modified residue | 446 | 1 | Phosphotyrosine Ref.21 | ||||||||||||||||||
| Modified residue | 453 | 1 | Phosphotyrosine Ref.12 | ||||||||||||||||||
| Modified residue | 486 | 1 | Phosphotyrosine; by SRC | ||||||||||||||||||
| Modified residue | 489 | 1 | Phosphotyrosine; by SRC | ||||||||||||||||||
Natural variations | |||||||||||||||||||||
| Alternative sequence | 264 – 300 | 37 | Missing in isoform 2 and isoform 3. | VSP_043120 | |||||||||||||||||
| Alternative sequence | 538 – 550 | 13 | YGLFP…VELRQ → FRELAFSCVRVALVPIKCSR DLPGQARGLRSALWRVGRKD CPRRGASSRVSLLGRRGLGL MEVNPELSHPEHRSCHVRWE ICLCHTVTARRIRKLISFLR SREAGPVPSCSQVGGVSFQK VTWKCLGTWVPECP in isoform 2. | VSP_043121 | |||||||||||||||||
Experimental info | |||||||||||||||||||||
| Sequence conflict | 495 | 1 | I → Y in AAA58455. Ref.1 | ||||||||||||||||||
Secondary structure | |||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||
| Beta strand | 497 – 499 | 3 | |||||||||||||||||||
| Beta strand | 506 – 510 | 5 | |||||||||||||||||||
| Beta strand | 518 – 523 | 6 | |||||||||||||||||||
| Beta strand | 526 – 534 | 9 | |||||||||||||||||||
| Beta strand | 537 – 542 | 6 | |||||||||||||||||||
| Helix | 543 – 545 | 3 | |||||||||||||||||||
| Beta strand | 546 – 548 | 3 | |||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas." Schuuring E.M.D., Verhoeven E., Mooi W.J., Michalides R.J.A. Oncogene 7:355-361(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Mammary gland. |
| [2] | "The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites." Schuuring E.M.D., Verhoeven E., Litvinov S., Michalides R.J.A. Mol. Cell. Biol. 13:2891-2898(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION. Tissue: Mammary gland. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). |
| [4] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3). Tissue: Placenta and Testis. |
| [7] | "Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER." Kim L., Wong T.W. J. Biol. Chem. 273:23542-23548(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FER, PHOSPHORYLATION OF CTTN, SUBCELLULAR LOCATION. |
| [8] | "Novel interaction of cortactin with endothelial cell myosin light chain kinase." Dudek S.M., Birukov K.G., Zhan X., Garcia J.G.N. Biochem. Biophys. Res. Commun. 298:511-519(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MYLK, PHOSPHORYLATION BY SRC. |
| [9] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [10] | "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." Nanda A., Buckhaults P., Seaman S., Agrawal N., Boutin P., Shankara S., Nacht M., Teicher B., Stampfl J., Singh S., Vogelstein B., Kinzler K.W., St Croix B. Cancer Res. 64:8507-8511(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PLXDC2. |
| [11] | "The proto-oncogene Fgr regulates cell migration and this requires its plasma membrane localization." Continolo S., Baruzzi A., Majeed M., Caveggion E., Fumagalli L., Lowell C.A., Berton G. Exp. Cell Res. 302:253-269(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION. |
| [12] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-453, MASS SPECTROMETRY. |
| [13] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405 AND SER-418, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Prostate cancer. |
| [16] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "Phosphoproteome of resting human platelets." Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A. J. Proteome Res. 7:526-534(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405 AND TYR-421, MASS SPECTROMETRY. Tissue: Platelet. |
| [18] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [19] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405; THR-411; SER-417 AND SER-418, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity." Jaworski J., Kapitein L.C., Gouveia S.M., Dortland B.R., Wulf P.S., Grigoriev I., Camera P., Spangler S.A., Di Stefano P., Demmers J., Krugers H., Defilippi P., Akhmanova A., Hoogenraad C.C. Neuron 61:85-100(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SRCIN1. |
| [21] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405; SER-418; TYR-421 AND TYR-446, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [22] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-87; LYS-198; LYS-235; LYS-272; LYS-304 AND LYS-309, MASS SPECTROMETRY. |
| [23] | "Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function." Dudek S.M., Chiang E.T., Camp S.M., Guo Y., Zhao J., Brown M.E., Singleton P.A., Wang L., Desai A., Arce F.T., Lal R., Van Eyk J.E., Imam S.Z., Garcia J.G.N. Mol. Biol. Cell 21:4042-4056(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH MYLK AND ABL1. |
| [24] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-399; THR-401; SER-405 AND SER-418, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [26] | "The immunoinhibitory adapter protein SRC homology domain 3 lymphocyte protein 2 (SLy2) regulates actin dynamics and B cell spreading." von Holleben M., Gohla A., Janssen K.P., Iritani B.M., Beer-Hammer S. J. Biol. Chem. 286:13489-13501(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SAMSN1. |
| [27] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-418, MASS SPECTROMETRY. |
| [28] | "Solution structures of the SH3 domain of human Src substrate cortactin." RIKEN structural genomics initiative (RSGI) Submitted (NOV-2005) to the PDB data bank Cited for: STRUCTURE BY NMR OF 485-550. |
| [29] | "Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis." Hashimoto S., Hirose M., Hashimoto A., Morishige M., Yamada A., Hosaka H., Akagi K., Ogawa E., Oneyama C., Agatsuma T., Okada M., Kobayashi H., Wada H., Nakano H., Ikegami T., Nakagawa A., Sabe H. Proc. Natl. Acad. Sci. U.S.A. 103:7036-7041(2006) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 490-550 IN COMPLEX WITH ASAP1, FUNCTION, INTERACTION WITH ASAP1 AND DNM2, SUBCELLULAR LOCATION. |
| + | Additional computationally mapped references. |
Web resources
| Wikipedia Cortactin entry |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M98343 mRNA. Translation: AAA58455.1. AK291097 mRNA. Translation: BAF83786.1. AP000487 Genomic DNA. No translation available. CH471076 Genomic DNA. Translation: EAW74766.1. CH471076 Genomic DNA. Translation: EAW74768.1. BC008799 mRNA. Translation: AAH08799.1. BC033889 mRNA. Translation: AAH33889.1. | ||||||||||||||||||
| IPI | IPI00029601. IPI00062884. IPI01013939. | ||||||||||||||||||
| PIR | A48063. | ||||||||||||||||||
| RefSeq | NP_001171669.1. NM_001184740.1. NP_005222.2. NM_005231.3. NP_612632.1. NM_138565.2. | ||||||||||||||||||
| UniGene | Hs.596164. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q14247. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | Q14247. 11 interactions. | ||||||||||||||||||
| MINT | MINT-5001258. | ||||||||||||||||||
| STRING | 9606.ENSP00000301843. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q14247. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 215273892. | ||||||||||||||||||
2D gel databases | |||||||||||||||||||
| OGP | Q14247. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q14247. | ||||||||||||||||||
| PRIDE | Q14247. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 2017. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000301843; ENSP00000301843; ENSG00000085733. ENST00000346329; ENSP00000317189; ENSG00000085733. ENST00000376561; ENSP00000365745; ENSG00000085733. | ||||||||||||||||||
| GeneID | 2017. | ||||||||||||||||||
| KEGG | hsa:2017. | ||||||||||||||||||
| UCSC | uc001opv.4. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 2017. | ||||||||||||||||||
| GeneCards | GC11P070244. | ||||||||||||||||||
| HGNC | HGNC:3338. CTTN. | ||||||||||||||||||
| HPA | CAB011235. | ||||||||||||||||||
| MIM | 164765. gene. | ||||||||||||||||||
| neXtProt | NX_Q14247. | ||||||||||||||||||
| PharmGKB | PA27775. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG123488. | ||||||||||||||||||
| HOGENOM | HOG000006523. | ||||||||||||||||||
| HOVERGEN | HBG005994. | ||||||||||||||||||
| KO | K06106. | ||||||||||||||||||
| OMA | SQQDYSK. | ||||||||||||||||||
| OrthoDB | EOG4RNB86. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Pathway_Interaction_DB | fgf_pathway. FGF signaling pathway. syndecan_3_pathway. Syndecan-3-mediated signaling events. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q14247. | ||||||||||||||||||
| Bgee | Q14247. | ||||||||||||||||||
| CleanEx | HS_CTTN. | ||||||||||||||||||
| Genevestigator | Q14247. | ||||||||||||||||||
| GermOnline | ENSG00000085733. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR015503. Cortactin. IPR003134. Hs1_Cortactin. IPR000108. p67phox. IPR001452. SH3_domain. [Graphical view] | ||||||||||||||||||
| PANTHER | PTHR10829:SF4. PTHR10829:SF4. 1 hit. | ||||||||||||||||||
| Pfam | PF02218. HS1_rep. 7 hits. PF00018. SH3_1. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR00499. P67PHOX. PR00452. SH3DOMAIN. | ||||||||||||||||||
| SMART | SM00326. SH3. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF50044. SH3. 1 hit. | ||||||||||||||||||
| PROSITE | PS51090. CORTACTIN. 7 hits. PS50002. SH3. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChiTaRS | CTTN. human. | ||||||||||||||||||
| EvolutionaryTrace | Q14247. | ||||||||||||||||||
| GenomeRNAi | 2017. | ||||||||||||||||||
| NextBio | 8171. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | SRC8_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q14247 Secondary accession number(s): Q8N707, Q96H99 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
